Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.32 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.32 |
| ▸ | SLC22A12 | Q96S37 | 2/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.31 |
| ▸ | RORA | P35398 | 1/20 | 0.31 |
| ▸ | RORC | P51449 | 1/20 | 0.31 |
| ▸ | RORB | Q92753 | 1/20 | 0.31 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | DRD2 | P14416 | 1/20 | 0.30 |
| ▸ | DRD4 | P21917 | 1/20 | 0.30 |
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17456530 | 0.84 | ELANE (0.39) | HSD11B1ELANENR1I2RORARORC | |
| SCHEMBL537825 | 0.81 | NR3C2 (0.33) | PTGS1PTGS2HSD11B1 | |
| SCHEMBL17839065 | 0.79 | CA2 (0.33) | CA2CA1 | |
| SCHEMBL17466333 | 0.79 | HTR6 (0.33) | SLC22A12 | |
| SCHEMBL196247 | 0.78 | NR1H2 (0.37) | CA2PTGS1PTGS2HSD11B1CA1 | |
| SCHEMBL196180 | 0.78 | NR1H2 (0.37) | CA2PTGS1PTGS2HSD11B1CA1 | |
| SCHEMBL12501660 | 0.78 | CA2 (0.38) | CA2CA1 | |
| SCHEMBL537935 | 0.77 | CA2 (0.36) | CA2PTGS1PTGS2CA1CA5A | |
| SCHEMBL17839117 | 0.76 | CA2 (0.33) | CA2CA1 | |
| SCHEMBL3857896 | 0.76 | CA2 (0.35) | CA2HSD11B1CA1NR1I2RORA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 234 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4673424-A1 | LIQUID PHASE PEPTIDE SUPPORT SYNTHESIS OF PEPTIDES AND PEPTIDOMIMETICS | Regeneron Pharmaceuticals, Inc. (US) | 2026-01-07 | — | — | EP | claimed |
| US-12331072-B2 | Deprotection method and resin removal method in solid-phase reaction for peptide compound or amide compound, and method for producing peptide compound | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-06-17 | — | — | US | claimed |
| WO-2025104679-A1 | PROCESSES FOR MAKING INTERMEDIATES FOR ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2025-05-22 | — | — | WO | claimed |
| WO-2025083736-A1 | NOVEL PROCESS FOR THE PREPARATION OF PIRTOBRUTINIB AND ITS INTERMEDIATES THEREOF | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) | 2025-04-24 | — | — | WO | claimed |
| CN-119253064-A | Multifunctional electrolyte and lithium metal battery | 江苏师范大学 | 2025-01-03 | — | — | CN | claimed |
| CN-113056475-B | Deprotection method for peptide compound or amide compound and resin removal method in solid phase reaction and method for producing peptide compound | 中外制药株式会社 | 2024-09-24 | — | — | CN | claimed |
| WO-2024182268-A1 | LIQUID PHASE PEPTIDE SUPPORT SYNTHESIS OF PEPTIDES AND PEPTIDOMIMETICS | REGENERON PHARMACEUTICALS, INC. (US) | 2024-09-06 | — | — | WO | claimed |
| CN-117683064-A | Preparation method of series of fluoro-calcitol CD ring related impurities | 正大制药（青岛）有限公司 | 2024-03-12 | — | — | CN | claimed |
| CN-117567300-A | Synthesis method of gamma-amino alcohol containing continuous chiral center | 江苏大学 | 2024-02-20 | — | — | CN | claimed |
| CN-117088798-A | Preparation method of fluoro-calcitol 22, 23-double bond impurity | 正大制药（青岛）有限公司 | 2023-11-21 | — | — | CN | claimed |
| CN-114276284-A | Preparation method of fluocalcitol | 正大制药（青岛）有限公司 | 2022-04-05 | — | — | CN | claimed |
| CN-113603631-A | Synthesis method of N-benzyl-3-hydroxypiperidine | 山东盛安贝新能源有限公司 | 2021-11-05 | — | — | CN | claimed |
| CN-113264972-A | Method for preparing obeticholic acid | 四川科伦药物研究院有限公司 | 2021-08-17 | — | — | CN | claimed |
| CN-111286021-A | Polyether terminated by silyl ether, preparation method thereof and efficient anti-mud water reducer | 安徽海螺新材料科技有限公司 | 2020-06-16 | — | — | CN | claimed |
| CN-108165303-B | Crude oil demulsifier and preparation method and use method thereof | 广昌达新材料技术服务（深圳）股份有限公司 | 2020-04-17 | — | — | CN | claimed |
| US-20090286996-A1 | PROCESS FOR THE PREPARATION OF ZILEUTON | DIPHARMA FRANCIS S.R.I. (IT) | 2009-11-19 | — | — | US | claimed |
| EP-0736052-B1 | PROCESS TO REACT EPOXIDE-CONTAINING COMPOUNDS AND ALIPHATIC ALCOHOLS | DOW CHEMICAL CO (US) | 1999-08-11 | — | — | EP | claimed |
| US-5728796-A | Process to react epoxide-containing compounds and aliphatic alcohols | THE DOW CHEMICAL COMPANY (US) | 1998-03-17 | — | — | US | claimed |
| US-4772683-A | SILYLATION, AZETIDONE THIOLESTERS | BRISTOL-MYERS COMPANY (US) | 1988-09-20 | — | — | US | claimed |
| US-4639335-A | ANHYDROPENICILLIN INTERMEDIATE | BRISTOL-MYERS COMPANY (US) | 1987-01-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12331072-B2 | Deprotection method and resin removal method in solid-phase reaction for peptide compound or amide compound, and method for producing peptide compound | VIP, PEPD, MLN | CA2 3250/4885PTGS1 2748/4885PTGS2 3176/4885 |
| US-20090286996-A1 | PROCESS FOR THE PREPARATION OF ZILEUTON | MPO, ZYX, F7 | CA2 967/4885PTGS1 2444/4885PTGS2 2559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.